India MCA Insolvency Liquidation Filings — March 11, 2026

NCLT New Delhi Bench approved amalgamation of Lumax Ancillary (Appointed Date Apr 1, 2024), scheme effective post-RoC filing, positive sentiment 9/10 materiality vs prior Feb 27 comm (QoQ resolution progress)

NCLT Cuttack sanctioned wholly-owned sub Godawari Energy amalgamation (App Date Apr 1, 2025), no new shares issued, synergies for financial flexibility, progressed from Aug 2025 consents (QoQ fast-track)

IBC Sec 7 insolvency application withdrawn post-settlement (NCLT Kolkata dismissal Mar 10, 2026), removes default risk overhang, positive sentiment 8/10

NCLT Bengaluru-directed demerger scheme EGM corrigendum issued, e-voting cutoff Mar 26, 2026 (vs prior Feb 26 notice), neutral sentiment but structural simplification ahead

Shareholder/creditor meetings dispensed due to consents (100% wholly-owned sub), regulatory notices to SEBI/BSE/NSE completed, capital allocation favors consolidation over dilution

Transferor dissolution without winding up post-scheme, enhances group efficiency, no financial impacts disclosed but positive vs neutral prior filings

Joint settlement with Carnex Timbers Pvt Ltd fully resolves dispute, no ongoing IBC proceedings, QoQ closure from filing to Mar 10 dismissal

100% promoter group shareholding extinguished under NCLT Hyderabad Jan 22, 2025 plan, contrasts peer consolidations but clears promoter debt

Public shareholders face 95% equity reduction (19/20 shares cancelled, new ₹10 share per 20 held), record date Mar 23, 2026, negative sentiment 10/10 materiality

Demerger between NH Integrated Care and NH Ltd per NCLT, documents at website, potential for unlocked value post-EGM Apr 2, 2026

95% public equity reduction (1 new share per 20), 100% promoter extinguish, record date Mar 23, 2026 under NCLT plan, erodes value no offsets

NCLT Hyderabad Jan 22, 2025 order mandates selective capital reduction, no positive financial ratios/operational metrics reported

Pending shareholder approval of demerger scheme at Apr 2, 2026 EGM via VC/OAVM, corrigendum on cutoff Mar 26 signals process risks if rejected

Amalgamation effective only post-RoC filing of certified NCLT order (not yet uploaded), delay risk vs App Date Apr 1, 2024

Sanctioned Mar 10, 2026 but effective post-RoC certified copy, prior delays from Aug-Oct 2025 updates highlight execution risk

NCLT dismissal order copy pending receipt, potential undisclosed settlement terms or recurrence risk

1/5 filings negative dilution amid restructurings, no insider buying signals conviction across cohort

NCLT approval unlocks synergies post-RoC filing, auto sector consolidation play, positive 9/10 materiality vs peers

Wholly-owned sub merger enhances financial strength/flexibility without dilution, power/steel sector alpha from efficiency gains

IBC withdrawal post-settlement clears litigation overhang, potential re-rating for undervalued diversified assets

EGM Apr 2, 2026 to approve NCLT scheme, healthcare unlocking via separation of integrated care unit

Dispensed meetings/ consents accelerate timeline from 2025 updates, capital allocation prioritizes internal growth

Ancillary dissolution without winding boosts ROE potential (inferred from no new shares), monitor website for order

4/5 positive outcomes (80%), manufacturing focus offers relative outperformance vs stagnant sectors

2/5 filings (Lumax Auto, Godawari Power) with NCLT sanctions for sub-mergers (App Dates 2024-25), 100% wholly-owned in one case, drives synergies without dilution—implication: manufacturing consolidation reduces costs 10-20% inferred

2/5 resolved positively (Williamson withdrawal, Fenoplast plan), but 1 with 95% dilution; QoQ progress from 2025 filings—implication: faster resolutions lower default risks sector-wide

All 3 approvals (Lumax, Godawari, Narayana) pending RoC filing post-sanction Mar 2026, prior comms show 6-7 month timelines—implication: near-term catalysts but execution volatility

Godawari/Lumax/Narayana schemes issue no new shares vs Fenoplast 95% cut, capital allocation favors existing holders—implication: relative value shift to non-dilutive restructurings

4/5 filings 8-10/10 materiality, positive sentiment 75%, healthcare/auto/power—implication: midcap restructuring alpha vs largecaps

Shareholder vote on demerger scheme, e-voting cutoff Mar 26, 2026, meeting Apr 2, 2026 via VC/OAVM—watch approval outcome [Apr 2, 2026]

95% share reduction/100% promoter extinguish under IBC plan, eligibility cutoff—monitor trading halt/price reaction [Mar 23, 2026]

NCLT amalgamation order certified copy filing for effectiveness (post Mar 11, 2026), website update www.lumaxworld.in [TBD post-Mar 11]

Scheme sanction Mar 10, 2026 effective post-RoC, Tribunal website order—track for synergies disclosure [TBD post-Mar 10]

Disclosure of dismissal order copy upon receipt, settlement details—watch for financial impact

Post-Feb 27, 2026 comm progression, any creditor reactions—monitor for full integration metrics [Ongoing]

Post-notice to SEBI/BSE/NSE/IT, any objections—track for scheme activation [Ongoing]